A two-serine insertion at position 69 (i69SS) of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) appears to be critical to enhance multi-nucleoside RT inhibitor resistance (MNR) in the sequence context of multiple zidovudine (AZT) resistance mutations (i.e., M41L, L210W, T215Y). In this study, we measured the replication capacity relative to the wild-type (WT) HIV-1 of a series of recombinant viruses carrying the i69SS in the background of a clinical isolate with MNR in which we introduced mutations D67N, Y215T, Y215S, or Y215N. In vitro measurements included replication kinetics and growth competition assays at different multiplicities of infection (MOI). While the addition of D67N had a minor effect on replication capacity, the reversion of Tyr-215 to Thr, Ser, or Asn was sufficient to increase the virus ability to replicate in a drug-free environment. The same genotypic changes at position 215 rendered the MNR virus susceptible to AZT and stavudine. Interestingly, the presence of the insertion together with mutation T215Y in an otherwise WT sequence background was not sufficient to confer high-level resistance to AZT, although its replication capacity was clearly impaired. Therefore, the RT residue 215 plays a critical role in both replication capacity and drug resistance of multidrug-resistant viruses containing the i69SS. D 2004 Elsevier Inc. All rights reserved.
Introduction
Human immunodeficiency virus type (HIV-1) infection is currently treated with highly active three-drug combination therapies. However, the emergence of drug resistanceassociated mutations is the major limitation to long-term treatment efficacy. Moreover, the fact that the 20 currently approved HIV-1 inhibitors for clinical use belong to only four different drug classes facilitates the appearance of cross-resistance among different drugs of the same family. The nucleoside analogue reverse transcriptase inhibitors (NRTIs) were the first type of compounds used for HIV treatment and are still part of almost all therapeutical regimens. Except for lamivudine, high-level resistance to NRTI is associated with multiple mutations in the reverse transcriptase (RT). Certain mutational pathways lead to the selection of RTs with multi-NRTI resistance (MNR). One of those patterns involves an insertion of two amino acids (often Ser -Ser, Ser-Gly, or Ser-Ala) between residues 69 and 70 of HIV-1 RT (Briones and Soriano, 1999; Briones et al., 2000; De Antoni et al., 1997; de Jong et al., 1999; Larder et al., 1999; Ross et al., 1999; Sugiura et al., 1999; Tamalet et al., 1998; Winters et al., 1998) . The insertion at position 69 has been described in about 2% of HIV-1infected patients that received prolonged therapy with zidovudine (AZT) together with (or followed by) administration of other NRTIs (Van Vaerenbergh et al., 2000) . The insertion is in the h3-h4 hairpin loop at the fingers subdomain of the RT and appears to be associated with multiple amino acid substitutions, including AZT-resistance mutations, such as T215Y. By themselves, the insertions cause low-level resistance to each of the NRTIs (Larder et al., 1999; Lennerstrand et al., 2001; Mas et al., 2000; Winters et al., 1998) , and drug resistance tests of recombinant patient isolates containing insertions together with T215Y/F and other AZT-resistance mutations showed reduced susceptibility to all NRTI (Dunne et al., 2001; Hertogs et al., 2000; Larder et al., 1999; Mas et al., 2000; Masquelier et al., 2001; Petropoulos et al., 2000; Winters et al., 1998) . Insertions between codons 69 and 70 have also been associated with resistance to tenofovir (Harrigan et al., 2002; White et al., 2004) . The insertion of two serines at codon 69 (i69SS) appears to be critical to enhance AZT and stavudine (D4T) resistance in the sequence context of a multidrug-resistant HIV-1 RT (Dunne et al., 2001; Hertogs et al., 2000; Larder et al., 1999; Mas et al., 2000; Masquelier et al., 2001; Petropoulos et al., 2000; Winters et al., 1998) . Phenotypic resistance to those thymidine analogues correlates with an increased ATP-dependent phosphorolytic activity that facilitates the efficient removal of the 3V-terminal nucleotide from NRTI-terminated primers (Lennerstrand et al., 2001; Mas et al., 2000 Mas et al., , 2002 .
In the absence of drugs, the insertion by itself does not confer any fitness disadvantage when occurring in a WT sequence context (i.e., HIV-1 BH10 ). However, it contributes to increase viral fitness of an HIV-1 isolate harboring the MNR genotype to levels that are roughly similar to those observed with the WT HIV-1 BH10 strain (with or without the insertion) (Quiñones-Mateu et al., 2002) . So far, two amino acid insertions between positions 69 and 70 have only been reported once in patients with primary HIV-1 infection (Daar et al., 2002) . Their low prevalence in HIVtreated patients suggests that its transmission fitness is also low.
In this work, we have measured the effect of mutations at codons 67 (D67N) and 215 (Y215T, Y215S, and Y215N) on the phenotypic susceptibility to NRTI and replication capacity of recombinant HIV-1 variants carrying the i69SS in the sequence background of a clinical multidrug-resistant isolate (Table 1) .
Results

Resistance to nucleoside analogue inhibitors
Recombinant HIV-1 clones were assayed to establish the level of resistance to NRTIs in clinical use (Table 2) . Within the context of a MNR genotype (including the i69SS), the addition of D67N, an AZT-resistance mutation, showed a minor effect in NRTI susceptibility. However, the reversion of Tyr-215 to Thr, Ser, or Asn rendered the MNR virus susceptible to AZT and D4T (Table 2) . These mutated viruses were also more sensitive to didanosine and zalcitabine inhibition. All recombinant viruses derived from the multidrug-resistant strain retained high levels of Table 1 Amino acid sequence differences between RTs from WT HIV-1 (BH10 strain) and recombinant virus derived from the multidrug-resistant clinical HIV-1 isolate (SS) 41 62 67 69 70 108 118 181 184 210 215
Only those amino acid differences found at codons associated with resistance to RTs are indicated (D'Aquila et al., 2003) . Six different plasmid constructions were generated containing RT sequences from the wild-type strain (BH10) and the sequence found in the clinical isolate (SS). The mutation G333E was also present in SS and mutants derived from this construct. The concentration of drug necessary to inhibit viral replication by 50% (IC 50 ) values represents the mean of three to six replicates. The fold increase in IC 50 relative to the wild-type virus control carrying the RT sequence of BH10 is shown between parenthesis. b In absence of drug. c Exponential growth constant or slope (m) derived from the equation log ( y) = mt + log (b), where y is a measure of virus quantity (i.e., pg of p24 per ml), t is time in days, and b is the y-intercept. d 95% confidence intervals (CI). e IC 50 values taken from Mas et al. (2000) for comparative purposes. This virus contained an RTBH10 in which codon 69 (Thr) has been replaced by three serines (T69SSS). lamivudine resistance as a result of the M184I mutation. Interestingly, the presence of the insertion together with mutation T215Y in an otherwise WT sequence background conferred a moderate increase of AZT resistance.
Replication kinetics
The growth rates of all tested recombinant viruses were similar to the one shown by WT HIV-1 (Table 2) . Moreover, differences observed between the WT and the virus showing the lowest replication capacity (i.e., SSSY) were not statistically significant.
Relative replicative fitness in virus mixtures
To measure viral fitness differences more accurately, dual infections were performed in cell culture. Replication capacity was determined in vitro relative to the WT at different multiplicity of infection (MOI) over 28 days. The proportions of WT and i69SS-containing viruses were estimated by length polymorphism detection methods ( Fig. 1 ). Before applying this detection system to growth competition experiments, we set up the method with different mixtures of plasmids containing an HIV-1 RT fragment with and without the i69SS. Fig. 1C demonstrates an excellent agreement and reproducibility between the expected and the measured values of dual mixtures of sequences with and without the i69SS. The method was sensitive at least down to 10% of one of the viral strains.
Competition growth assays were performed with different MOIs. We could observe differences in the outcome of the competitions between a MOI of 0.01 and 0.001, the latter one showing the most significant differences among the different viral strains compared. For example, at an MOI of 0.01, fitness differences between the WT virus and the mutant SS/215S were not significant. However, when the MOI was reduced to 0.001, the WT tended to outgrow the SS/215S (Fig. 2B ). A similar behavior was observed in fitness competition assays with WT HIV-1 and mutant SS/67N. While at an MOI of 0.01, the mutant was slightly overgrown by the WT virus, at a lower MOI (0.001), the WT viruses had taken over the population by day 14 of culture ( Fig.  2B ). Interestingly, antigen p24 levels increased steadily during the first 6 days postinfection, at least during the first two passages, when infections were carried out at an MOI of 0.001 ( Fig. 2A ). However, at higher MOIs (i.e., 0.01), maximum p24 levels were already detected within the first 3 days after infection in all assays. These results, which were also consistent with simultaneous determinations of cell viability (data not shown), justify why the lower MOI is more efficient to distinguish subtle differences in fitness between the competing viruses.
All tested viruses had a replication capacity lower than the WT when assayed in a drug-free environment for an MOI of 0.001 ( Fig. 3) . Thus, even when infections were initiated with an excess of mutant virus (right panel of each competition in Fig. 3 ), the WT virus outgrew the mutant viruses SS, SSSY, SS/67N, and SS/215N before day 15 of culture, while the shift occurred later for viruses SS/215S and SS/215T. In fact, the loss of fitness of these two viruses in comparison with the WT strain did not reach statistical significance. Fitness competition experiments gave consistent results, either when infections were initiated with an excess of mutant or with an excess of WT virus. Interestingly, the presence of the insertion together with mutation T215Y in an otherwise WT background (as in mutant SSSY) impaired fitness, rendering viruses with a replication capacity similar to that shown by the SS strain or the SS/67N mutant (Fig.  4) . When the SS virus was used for comparison, SS/215T and SS/215S were significantly fitter (P < 0.05) ( Fig. 4) . Recombination between the two input viruses was not detected by sequencing population-based PCR products at the end of the co-culture.
Discussion
A dipeptide insertion at position 69 in combination with T215Y/F and other thymidine-analogue-resistance mutations has been considered as a mutational pattern characteristic of MNR. This mutational pattern, however, is responsible for only a minority of resistant isolates: it is present in about 1% of the patients treated with at least one NRTI and 3% of the patients treated with more than three NRTIs (Stanford HIV RT and Protease Sequence Database; http://www.hivdb.stanford.edu; Rhee et al., 2003) . Previous reports described the role of the two serine insertion at positions 69/70 of the HIV-1 RT on NRTI resistance and the biochemical mechanism involved, as well as their influence on viral fitness in either a WT RT sequence background or in the context of a multidrug-resistant RT derived from a clinical isolate (designated as SS) Quiñones-Mateu et al., 2002) . In the present study, we analyzed the effects on viral fitness and NRTI susceptibility of adding a new mutation in the h3-h4 hairpin loop at the fingers subdomain of the RT or reverting Tyr-215 to its WT genotype (Thr-215) or to other less common amino acids (i.e., Ser or Asn). Our results showed that the introduction of mutation D67N in the multidrug-resistant SS variant had no measurable effect on viral fitness or resistance to NRTIs. However, the reversion of Tyr-215 to Thr, Ser, or Asn in the sequence context of a MNR background, including the 69 insertion, rendered viruses susceptible to AZT and D4T, whose viral fitness increased in the absence of drug. Our results indicate that the RT residue 215 plays a critical role in both drug resistance and replication capacity of MNR viruses containing the i69SS. In the context of an MNR virus, the reversion of Tyr-215 to Thr that involves two nucleotide changes, or its substitution by Ser or Asn, which requires only one nucleotide substitution, is sufficient to recover full susceptibility to AZT and D4T due to the loss of the ATP-dependent unblocking activity (Matamoros et al., 2004) as well as to increase the viral replication capacity in the absence of drugs. However, the interpretation of the data might be somehow limited by the use of a single primary isolate-derived RT sequence.
It has been shown that, after discontinuation of AZT in patients harboring AZT-resistant strains of HIV-1 (i.e., isolates carrying mutations M41L, D67N, T215Y/F, K219Q/E,. . .) or in newly infected individuals who had acquired an AZT-resistant virus by transmission, resistant variants were eventually replaced by AZT-susceptible revertants that often contained unusual amino acids at codon 215, such as Asp, Asn, Cys, or Ser, through mutations involving one nucleotide change (de Ronde et al., 2001; García-Lerma et al., 2001; Yerly et al., 1998) . These partial revertants appear to be fitter than the virus having Tyr-215 when tested in growth competition experiments (de Ronde et al., 2001; García-Lerma et al., 2001; Yerly et al., 1998) . However, those studies included only viruses with three or less NRTI resistanceconferring mutations, and none of them contained the i69SS (de Ronde et al., 2001; García-Lerma et al., 2001; Lukashov et al., 2001; Yerly et al., 1998) . In contrast, our recombinant viruses had a MNR genotype that included the i69SS and at least 10 RT inhibitor-associated resistance mutations. It has also been reported that, in vivo, there is a competitive disadvantage of the insertion mutant compared to the WT virus when therapy is withdrawn (Lukashov et al., 2001) . However, the presence of the insertion was always linked to the presence of Tyr at position 215, making difficult to elucidate whether the insertion or the change at position 215 was responsible for the loss of fitness of the HIV-1 isolates. In addition, removing the dipeptide insertion from a MNR HIV-1 isolate did further reduce its viral fitness (Quiñones-Mateu et al., 2002) . This would suggest that the insertion by itself has a limited effect in replication capacity. In contrast, Asn-215, Ser-215, or Thr-215 appears to increase viral fitness and reduce AZT and D4T resistance in different sequence backgrounds. To our knowledge, there is only one report showing co-infection with an HIV isolate containing the 69 insertion and a wild-type HIV strain (Daar et al., 2002) . This low transmission rate could be due in part not only to the low prevalence of the insertion in HIV-treated patients, but also to a potentially poor transmission of these variants because of their low viral fitness. Therefore, the in vivo influence of the reversion from Tyr-215 to Asn, Ser, or Thr in such MNR context is unknown, but their clinical relevance cannot be ruled out.
The presence of the 6-bp insertion between codons 69 and 70 allowed us to obtain length polymorphism results from growth competition experiments involving two HIV-1 strains, one of them containing the insertion. This technique rendered a high throughput and a dynamic quantification range easily detecting down to 10% of any of the viral variants. Sensitivity was two-to three-fold higher than using relative peak heights in electropherograms obtained by automated sequencing. To verify that the out-competing strain was the WT HIV-1 and not a fitter recombinant virus lacking the 6-bp insertion, we obtained population-based sequences at the end of all growth dual-competition cultures. All sequences showed that, in agreement with the length polymorphism results, the dominant virus was the Fig. 4 . Determination of the relative replication efficiencies of recombinant HIV-1 strains containing the 69 insertion in the RT-coding region vs. a WT virus as determined from growth competition experiments. Horizontal dotted line represents the fitness vector for the WT virus. Other vectors show variations in the relative amounts of mutant vs. WT ratios during passages in cell culture. Each of the six RT mutants (SS, SSSY, SS/215S, SS/215N, SS/215T, and SS/67N) was mixed with WT in independent competition cultures at a starting mutant to WT ratio of 4:1. Slopes were calculated by fitting linear models using the method of least squares. All viruses were less fit than the wild-type (P < 0.01). Asterisks indicate recombinant viruses that are fitter than the SS (P < 0.05). se, standard error. R 2 , coefficient of determination.
WT at day 28. Similarly, RT sequencing revealed that individual infectious molecular clones used in replication kinetics based on levels of the p24 antigen had a stable genotype over the time of culture.
In this study, we have used recombinant viruses whose replication kinetics were quite similar. In this setting, the competitive-culture approach was more efficient than monitoring viral growth through detection of the p24 antigen in discriminating small differences between viral strains (Martinez-Picado et al., 1999; Prado et al., 2002; Quiñones-Mateu et al., 2002) . Differences in relative fitness between the two competing recombinant HIV strains were more clearly observed when dual infections were performed at lower MOIs. Thus, while marginal or no viral population changes were observed over time at an MOI of 0.01, the differences were relevant at a 10fold lower infectivity (MOI of 0.001). Although such effect had never been described for HIV-1, a similar phenomenon has been observed when two closely related subpopulations of foot-and-mouth disease virus (FMDV) were subjected to growth-competition experiments in BHK-21 cells (Sevilla et al., 1998) . One of the populations was found to have a selective advantage over the other only when the competition passages were carried out at low MOI. Conversely, populations coexisted during serial passages carried out at high MOI, suggesting that small differences in the interaction of the virus with the host cell may contribute to a MOI-dependent selective advantage of one viral subpopulation over a closely related subpopulation (Sevilla et al., 1998) . In our HIV-1 growth-competition experiments, p24 antigen production was saturated after 3 days of culture at higher MOI; however, it remained closer to an exponential phase over the 7-day culture at lower MOI ( Fig. 2A) . This might indicate that at an MOI of 0.001, there was a higher number of viral replication cycles allowing the two viral strains to reach a higher level of competition. Although speculative, another molecular mechanism underlying MOI-dependent fitness might rely to functional complementation between the two viruses at high MOI. Thus, assuming that infection of susceptible cells by more than one virus happens more frequently at higher MOI, WT RT might complement the activity of a slightly less processive mutant RT.
In conclusion, the RT residue 215 plays a critical role in both drug resistance and replication capacity of MNR viruses containing the i69SS. Thus, the reversion of Tyr-215 to Thr, Ser, or Asn in the sequence context of an MNR virus is sufficient to recover full susceptibility to AZT and D4T as well as to increase replicative capacity in absence of drug. Moreover, Tyr-215 and i69SS were enough to reduce viral fitness in the absence of high levels of phenotypic resistance to NRTIs regardless of the presence of other NRTI-associated mutations. Additionally, we have demonstrated here that fitness differences of two competing recombinant HIVs are MOI-dependent.
Materials and methods
Patient sample
The plasma sample was obtained from a heavily treated HIV-infected individual as part of a previous study that screened HIV-1-infected patients for the presence of virus with insertions in the fingers subdomain of HIV-1 RT (Briones and Soriano, 1999) . The donor was an HIVinfected 38-year-old man who had been extensively treated with several RT and protease inhibitors, including an initial treatment with AZT in monotherapy (1992 -1996) and a current regimen at the time of plasma withdrawal combining five anti-retroviral drugs (D4T, dideoxyinosine, nevirapine, saquinavir, and nelfinavir). Viral RNA was extracted from plasma and the RT-coding region was RT-PCR-amplified and cloned as previously described Mas et al., 2000) . Sequencing of the HIV-1 pol gene showed that apart from the insertion of two serines between codons 69 and 70, it contained 43 additional mutations scattered throughout the entire RT-coding sequence, including 10 amino acid substitutions related to drug resistance (D'Aquila et al., 2003) .
Generation of recombinant viruses
The recombinant viruses containing the RT-coding regions of a WT HIV-1 strain (BH10) or of the MNR HIV primary isolate mentioned above (SS) were constructed as previously described . Mutations D67N (SS/67N), Y215T (SS/215T), Y215S (SS/ 215S), and Y215N (SS/215N) were introduced by sitedirected mutagenesis in a plasmid carrying the nucleotide sequence encoding the 66-kDa subunit of SS RT (Matamoros et al., 2004) (Table 1 ). In addition, mutation T215Y was introduced in a plasmid encoding a mutated p66 subunit of BH10 RT, which contained the T69SSS insertion , to obtain the mutant SSSY (Matamoros et al., 2004) (Table 1) . A PCR-amplified fragment containing the full-length RT-coding region was co-transfected with an RT-deleted HXB2-D clone in SupT1 cells (Kellam and Larder, 1994) . Harvested viruses were propagated in MT-4 cells. The 50% tissue culture-infectious dose (TCID 50 ) in each virus stock was determined in the same cell line by using the method of Reed and Muench (1938) .
Phenotypic analysis
Phenotypic susceptibility to nucleoside RT inhibitors of the new HIV variants was tested in vitro by the MTT assay (Pauwels et al., 1988) . Phenotypic resistance was determined by measuring fold increase in 50% inhibitory concentration (IC 50 ) values compared with the reference WT HIV-1 HXB2 strain carrying the RT-coding region of BH10.
Analysis of replication kinetics
Inocula of 5000 TCID 50 of each virus were used to infect 5 Â 10 6 MT-4 cells (multiplicity of infection of 0.001) as previously described (Martinez-Picado et al., 1999; Prado et al., 2002) . After incubation for 2 h at 37 jC, cells were washed twice with phosphate-buffered saline and resuspended in RPMI 1640 (Sigma) supplemented with 10% fetal calf serum (Sigma), 10 mM HEPES buffer (Invitrogen), 50 mg of penicillin/ml, and 50 mg of streptomycin/ml (Invitrogen) at a concentration of 0.5 Â 10 6 cells/ml. Duplicates of 5-ml cultures were incubated in 6-well tissue culture plates (Nunc) in the absence of drugs. Supernatants (200 Al) from each culture were collected every day, and then an equal volume of culture media was added. Levels of p24 antigen were quantitated in cell-free culture supernatants by using the HIV-1 p24 antigen assay (Innogenetics) and were used to monitor replication kinetics. Growth kinetics based on p24 production were analyzed by fitting a linear model to the log-transformed p24 data from the replicates for each mutant by maximum likelihood methods (Martinez-Picado et al., 2000; Prado et al., 2002) . For a given mutant, the growth rate based on p24 production was assumed to be the same between replicates, but the initial level of p24 was allowed to vary between replicates according to a normal distribution. Missing values were assumed to be missing at random. This model was found to give a good fit to the data.
Analysis of relative replicative fitness in virus mixtures
Growth competition assays were performed in MT-4 cells in absence of drug as described elsewhere (Martinez-Picado et al., 2000; Prado et al., 2002) . Multiplicities of infection (MOI) of 0.01 and 0.001 were assayed. Infections were initiated with unequal amounts of two competing virus variants according to virus infectivity titrations. Unequal ratios were used based on the rationale that an increase in proportion of the initially less abundant virus suggests a relatively better replicative capacity than the competing, initially more abundant virus, although random factors cannot be excluded with either unequal or equal starting ratios. Five-milliliter cultures were maintained in 6-well tissue culture plates at 0.5 Â 10 6 cells/ml. At day 3 of the first passage, half of the culture was replaced with fresh medium. At day 7, fresh MT-4 cells were reinfected with a dilution 1:100 of the supernatant and cultured at 0.5 Â 10 6 cells/ml. Three additional passages were performed in the same way. Aliquots were removed from the cultures at days 3, 7, 10, 14, 17, 21, 24, and 28, centrifuged, total genomic DNA was extracted from the cells (Qiamp DNA blood Mini kit; Qiagen) for genotypic analysis (Fig. 1) , and supernatants were stored at À80 jC. Levels of p24 antigen were quantitated in cell-free culture supernatants of all time points to monitor replication kinetics of the competitions. The number of viable cells was also determined with trypan blue. Genotyping was performed at the end of each competition by using the d-Rhodamine Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) and subsequent electrophoresis in an automated sequencer (either an ABI PRISM 310 or 377; Applied Biosystems). MT-4 cells were also separately infected with mutants in the absence of WT virus to assess possible spontaneous reversion of the mutated codons.
Length polymorphisms detection
DNA was PCR-amplified in triplicate with primers RT2696 -2725 (5VFAM-AAT TGG GCC TGA AAA TCC ATA CAA TAC TCC-3V , where FAM is 6-carboxyfluorescein) and RT2839 -2812 (5V-GGA TGT GGT ATT CCT AAT TGA ACT TCC C-3V) by using Platinum Taq High Fidelity polymerase (Invitrogen) and 25 thermal cycles (30 s at 94 jC, 30 s at 55 jC, and 30 s at 68 jC). One microliter of PCR products was mixed with 20 Al of formamide and 1 Al of the molecular size marker labeled with carboxytetramethyl rhodamine (Applied Biosystems) ( Fig. 1A) . DNA fragments were separated under denaturing conditions in a capillary electrophoresis analysis, and results were analyzed with the GeneScan software (Applied Biosystems), as previously described . The area of each peak divided by the total area of the two peaks was used to determine the relative proportion of the two competing variants in each time point (Fig. 1B) . Viral RNA was also extracted from the culture supernatants, reverse transcribed, and PCR amplified in one step by using the OneStep reverse transcription-PCR kit (Qiagen) with the same primers indicated above.
The reproducibility and robustness of the length polymorphisms detection method were tested by mixing known amounts of plasmids that contained the HIV-1 RT-coding region with and without the i69SS.
Statistical analysis
Statistical analyses were performed using the R language (http://www.r-project.org) and the SPSS programs ver-sion10.0.6 (SPSS Inc., Chicago, IL). acknowledged. We thank Nuria Pérez for assistance with the statistical analysis.
